SCHEMBL67338

SCHEMBL67338

COc1cc(O)c(O)c(O)c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.67
ALDH1A1 P00352 2/20 0.56
CA1 P00915 1/20 0.52
CA2 P00918 1/20 0.52
ABL1 P00519 3/20 0.50
BCR P11274 3/20 0.50
ABCB1 P08183 2/20 0.50
PTPN1 P18031 1/20 0.50
MAPK1 P28482 3/20 0.48
USP2 O75604 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
ERN1 O75460 1/20 0.48
TDP1 Q9NUW8 2/20 0.48
SELL P14151 1/20 0.48
SELP P16109 1/20 0.48
SELE P16581 1/20 0.48
HPGD P15428 2/20 0.47
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
KDM4E B2RXH2 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4445709 0.87 CYP3A4 (0.59) CYP3A4ALDH1A1CA1CA2ABL1
SCHEMBL10106588 0.85 CYP3A4 (0.62) CYP3A4ALDH1A1CA1CA2ABL1
SCHEMBL4646583 0.80 TDP1 (0.75) CYP3A4ALDH1A1CA1CA2ABL1
2,6-Dihydroxy-4-Methoxytoluene SCHEMBL1607351 0.80 CYP3A4 (1.00) CYP3A4ALDH1A1CA1CA2ABL1
SCHEMBL70237 0.79 CA2 (0.80) CYP3A4ALDH1A1CA1CA2ABL1
SCHEMBL16191631 0.79 CYP1A1 (0.71) CYP3A4ALDH1A1ABL1BCRABCB1
SCHEMBL16191630 0.79 CYP1A1 (0.71) CYP3A4ALDH1A1ABL1BCRABCB1
Flamenol SCHEMBL69428 0.79 CYP3A4 (0.62) CYP3A4ALDH1A1CA1CA2ABL1
SCHEMBL233829 0.79 ALDH1A1 (0.69) CYP3A4ALDH1A1CA1CA2ABL1
SCHEMBL24445820 0.78 ALDH1A1 (0.50) CYP3A4ALDH1A1CA1CA2ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105527803-A Photoresist cleaning fluid ANJI MICROELECTRONICS (SHANGHAI) CO LTD 2016-04-27 CN claimed
EP-3571180-B1 PRODUCTION OF HIGHLY PURE META,META-COUPLED BIS(4-ALKYLPHENOL) DERIVATIVES AND USES THEREOF UNIV LEUVEN KATH (BE) 2024-12-18 EP disclosed
US-20240016971-A1 PHENOL DERIVATIVE-MODIFIED, TISSUE-DERIVED EXTRACELLULAR MATRIX DERIVATIVE FOR CONSTRUCTION OF ARTIFICIAL TISSUE Cellartgen Inc. (KR) 2024-01-18 US disclosed
US-20230400770-A1 Resist Underlayer Film Material, Patterning Process, And Method For Forming Resist Underlayer Film SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-12-14 US disclosed
US-20230400770-A1 Resist Underlayer Film Material, Patterning Process, And Method For Forming Resist Underlayer Film SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-12-14 US disclosed
US-20230296982-A1 POLYMER, COMPOSITION, METHOD FOR PRODUCING POLYMER, COMPOSITION, COMPOSITION FOR FILM FORMATION, RESIST COMPOSITION, RADIATION-SENSITIVE COMPOSITION, COMPOSITION FOR UNDERLAYER FILM FORMATION FOR LITHOGRAPHY, RESIST PATTERN FORMATION METHOD, METHOD FOR PRODUCING UNDERLAYER FILM FOR LITHOGRAPHY, CIRCUIT PATTERN FORMATION METHOD, AND COMPOSITION FOR OPTICAL MEMBER FORMATION MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2023-09-21 US disclosed
US-20220163890-A1 RESIST UNDERLAYER FILM MATERIAL, PATTERNING PROCESS, AND METHOD FOR FORMING RESIST UNDERLAYER FILM SHIN-ETSU CHEMICAL CO., LTD. (JP) 2022-05-26 US disclosed
US-20210251945-A1 COMPOUNDS AND PHARMACEUTICAL USES THEREOF SYNEURX INTERNATIONAL (TAIWAN) CORP. (TW) 2021-08-19 US disclosed
US-20210070684-A1 PRODUCTION OF HIGHLY PURE META,META-COUPLED BIS(4-ALKYLPHENOL) DERIVATIVES AND USES THEREOF KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2021-03-11 US disclosed
WO-2020227437-A1 SUSTAINED RELEASE SOLID DOSAGE FORMS FOR MODULATING THE COLONIC MICROBIOME AXIAL BIOTHERAPEUTICS, INC. (US) 2020-11-12 WO disclosed
EP-0650476-A1 PERIPHERAL VASODILATING AGENT CONTAINING N-ACYLATED 4-AMINO PIPERIDINE DERIVATIVES AS ACTIVE INGREDIENTS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1995-05-03 EP disclosed
WO-1994022826-A1 PERIPHERAL VASODILATING AGENT CONTAINING N-ACYLATED 4-AMINO PIPERIDINE DERIVATIVES AS ACTIVE INGREDIENTS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1994-10-13 WO disclosed
US-5087548-A POSITIVE TYPE RADIATION-SENSITIVE RESIN COMPOSITION JAPAN SYNTHETIC RUBBER CO., INC. (JP) 1992-02-11 US disclosed
EP-0054258-B1 PHOTOSENSITIVE COMPOSITIONS KONICA CORPORATION (JP) 1986-03-05 EP disclosed
US-4477553-A AN O QUINONEDIAZIDE AND A DIHYDROXYBENZENE-BASED PHENOLIC OR POLYPHENYL RESIN BINDER; LITHOGRAPHIC PRINTING PLATES KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) 1984-10-16 US disclosed
EP-0021718-B1 PHOTOSENSITIVE CONDENSATION PRODUCT, PHOTOSENSITIVE COMPOSITIONS AND LITHOGRAPHIC PRINTING PLATES CONTAINING SAID CONDENSATION PRODUCT KONICA CORPORATION (JP) 1984-03-21 EP disclosed
EP-0054258-A2 Photosensitive compositions KONICA CORPORATION (JP) 1982-06-23 EP disclosed
US-4306010-A Photosensitive o-quinone diazide composition and photosensitive lithographic printing plate KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) 1981-12-15 US disclosed
EP-0021718-A1 Photosensitive condensation product, photosensitive compositions and lithographic printing plates containing said condensation product KONICA CORPORATION (JP) 1981-01-07 EP disclosed
US-3987109-A POLYMERIZATION OF POLYFUNCTIONAL PHENOLS UNIVERSAL OIL PRODUCTS COMPANY (US) 1976-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210070684-A1 PRODUCTION OF HIGHLY PURE META,META-COUPLED BIS(4-ALKYLPHENOL) DERIVATIVES AND USES THEREOF MMS19, PCBP1, PBRM1 CYP3A4 48/4885ALDH1A1 1877/4885CA1 4655/4885
US-20240016971-A1 PHENOL DERIVATIVE-MODIFIED, TISSUE-DERIVED EXTRACELLULAR MATRIX DERIVATIVE FOR CONSTRUCTION OF ARTIFICIAL TISSUE F3, F12, F2 CYP3A4 1000/4885ALDH1A1 805/4885CA1 4224/4885
US-20210251945-A1 COMPOUNDS AND PHARMACEUTICAL USES THEREOF ACE, ACE2, FURIN CYP3A4 143/4885ALDH1A1 1580/4885CA1 2176/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.